Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos Cholongitas

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Clinical Journal of Gastroenterology|January 9, 2022
The impact of emricasan on chronic liver diseases: current dataVasileios Lekakis, Evangelos Cholongitas
World Journal of Hepatology|May 29, 2014
Μanagement of patients with hepatitis B and C before and after liver and kidney transplantationChrysoula Pipili, Evangelos Cholongitas
Annals of Gastroenterology|July 3, 2023
Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugsEvgenia Koureta, Evangelos Cholongitas
Current Pharmaceutical Design|January 18, 2019
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current ConceptsMargarita Papatheodoridi, Evangelos Cholongitas
World Journal of Hepatology|July 4, 2015
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Chrysoula Pipili, Evangelos Cholongitas
World Journal of Gastrointestinal Pharmacology and Therapeutics|August 19, 2014
Renal dysfunction in patients with cirrhosis: Where do we stand?Chrysoula Pipili, Evangelos Cholongitas
Gastrointestinal Tumors|November 11, 2020
Long-Term Survival under Arterial Chemoembolization and Sorafenib of a Patient with Hepatocellular Carcinoma and Tumor Atrial Thrombus: A Case Report and Literature ReviewAndreas Mavroudis, Evangelos Cholongitas
World Journal of Gastrointestinal Pharmacology and Therapeutics|November 12, 2015
Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipientsChrysoula Pipili, Evangelos Cholongitas
Frontiers in Pharmacology|March 11, 2024
Evolving role of semaglutide in NAFLD: in combination, weekly and oral administrationEvgenia Koureta, Evangelos Cholongitas
Auto- Immunity Highlights|May 23, 2015
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspectsEvangelos Cholongitas, Andrew K Burroughs
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Clinical Journal of Gastroenterology|January 9, 2022
The impact of emricasan on chronic liver diseases: current dataVasileios Lekakis, Evangelos Cholongitas
World Journal of Hepatology|May 29, 2014
Μanagement of patients with hepatitis B and C before and after liver and kidney transplantationChrysoula Pipili, Evangelos Cholongitas
Annals of Gastroenterology|July 3, 2023
Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugsEvgenia Koureta, Evangelos Cholongitas
Current Pharmaceutical Design|January 18, 2019
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current ConceptsMargarita Papatheodoridi, Evangelos Cholongitas
World Journal of Hepatology|July 4, 2015
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Chrysoula Pipili, Evangelos Cholongitas
World Journal of Gastrointestinal Pharmacology and Therapeutics|August 19, 2014
Renal dysfunction in patients with cirrhosis: Where do we stand?Chrysoula Pipili, Evangelos Cholongitas
Gastrointestinal Tumors|November 11, 2020
Long-Term Survival under Arterial Chemoembolization and Sorafenib of a Patient with Hepatocellular Carcinoma and Tumor Atrial Thrombus: A Case Report and Literature ReviewAndreas Mavroudis, Evangelos Cholongitas
World Journal of Gastrointestinal Pharmacology and Therapeutics|November 12, 2015
Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipientsChrysoula Pipili, Evangelos Cholongitas
Frontiers in Pharmacology|March 11, 2024
Evolving role of semaglutide in NAFLD: in combination, weekly and oral administrationEvgenia Koureta, Evangelos Cholongitas
Auto- Immunity Highlights|May 23, 2015
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspectsEvangelos Cholongitas, Andrew K Burroughs
Pageof 18